Professor Christine Mummery is one of the founders of stem cell medicine in the Netherlands. Her work focuses on understanding cardiovascular development and disease mechanisms, ultimately hoping to find personalized treatments for patients suffering from cardiovascular disease.
Professor Christine Mummery is a pioneer in stem cell medicine. In 2007, she introduced the method for turning adult human cells, like skin cells or blood cells, into stem cells in the Netherlands. These cells are called human induced pluripotent stem cells (hiPSC). Professor Mummery’s team uses hiPSCs to develop miniature organs, so-called organ-on-chip models, or cardiac microtissues and cardioids. The group’s area of expertise is cardiovascular disease. The organs-on-chip are used to study the development of blood vessels and heart tissue, and related disease mechanisms. By making organs-on-chip and cardiac microtissues from patients with cardiovascular diseases, it is possible to test multiple treatments and find the one that suits each individual patient best.
Professor Mummery is a principal investigator at Leiden University Medical Center (LUMC) within reNEW as well as the theme lead of its research pillar reSOLVE. In addition, she is the lead of the iPSC and Organ-on-Chip hotel. These facilities, located at LUMC, support several groups of researchers within reNEW.
Professor Mummery has been recognised for her contribution to stem cell medicine with many awards. In addition, she has led numerous international organizations and initiatives including the International Society of Stem Cell Research (ISSCR) and the European Organ on Chip Society (EUROoCS). She currently holds a position as professor of Developmental Biology at LUMC.
reNEW researchers have a strong track record of scientific excellence in stem cell biology
They have performed pioneering work in stem cell research spanning different tissue and cell types, different technological advances and different stages of applied research. This provides an unprecedented international opportunity to utilise the combined wealth of knowledge, complementary skills sets and clinical experience across reNEW to push stem cell discoveries toward translational outcomes.